imlunestrant
eli lilly
['imlunestrant']
encouraging outcomes observed in the phase 1 trial of the novel serd imlunestrant (k. jahveri et al.), with 6.5 moths of pfs when used in 2l at progression to cdk4/6 inhibitors #asco22 
Paolo Tarantino, MD, (@PTarantinoMD) #BCSM Researcher from @IEOufficiale, takes over our Twitter today to discuss #ASCO22.